FDA
approval
· 2024-03-20
FDA Approved: BUPRENORPHINE AND NALOXONE — Supplemental Application (INGENUS PHARMACEUTICALS, LLC)
Summary
The FDA approved a supplemental application for buprenorphine and naloxone from Ingenus Pharmaceuticals, LLC, confirming approval of the generic combination for…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for BUPRENORPHINE AND NALOXONE (BUPRENORPHINE AND NALOXONE)